Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$7.79 USD

7.79
1,013,423

+0.04 (0.52%)

Updated May 10, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 251)

Industry: Technology Services

Better trading starts here.

Zacks News

Allscripts' (MDRX) Q3 Earnings Beat Estimates, Margins Up

Allscripts' (MDRX) robust Q3 results demonstrate strength in both segments.

AllScripts Healthcare (MDRX) Q3 Earnings Surpass Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of 50.00% and -1.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate AllScripts Healthcare (MDRX) to Report a Decline in Earnings: What to Look Out for

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain Allscripts (MDRX) Stock For Now

Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and various innovation milestones.

Allscripts' (MDRX) New AI-Based Offering to Improve Patient Care

Allscripts' (MDRX) latest AI-based scheduling application is expected to provide improved patient care as well as increase operational efficiencies of the healthcare system.

Cerner's (CERN) Latest Offering to Improve RCM Portfolio

Cerner's (CERN) latest offering is likely to streamline and automate revenue cycle via interoperability and enhanced usability.

Allscripts (MDRX), CareMetx Tie Up for Better Patient Care

Allscripts' (MDRX) Veradigm enters collaboration with CareMetx to streamline specialty medication management for medical clinics and practices across the nation.

Syneos Health's (SYNH) New Pact Boosts Tech-Driven Solutions

Syneos Health's (SYNH) recent acquisition boosts the company's ability to deliver strategic insights and technology-enabled solutions that address the customers' most complex data challenges.

Here's Why You Should Retain Allscripts (MDRX) Stock For Now

Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and solid prospects of the Sunrise EHR platform.

Here's Why You Should Retain CONMED (CNMD) Stock for Now

Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.

Allscripts' (MDRX) Shares Up Following Q2 Earnings Beat

Allscripts' (MDRX) robust Q2 results demonstrate its strength in Client services segment.

AllScripts Healthcare (MDRX) Surpasses Q2 Earnings and Revenue Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of 27.78% and 0.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

AllScripts Healthcare (MDRX) to Report Q2 Results: What to Know Ahead of the Release

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Debanjana Dey headshot

MedTech Thrives on Healthcare IT in 2021: 4 Stocks to Focus on

Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months.

Riya Anand headshot

3 Stocks in Focus on Evolving MedTech Trends Amid COVID-19

Stocks like Allscripts Healthcare Solutions (MDRX), National Vision Holdings (EYE) and Quest Diagnostics (DGX) are in focus on evolving MedTech trends.

The Zacks Analyst Blog Highlights: Boyd Gaming, International Game Technology, Allscripts Healthcare, Zoom Video and Thryv Holdings

The Zacks Analyst Blog Highlights: Boyd Gaming, International Game Technology, Allscripts Healthcare, Zoom Video and Thryv Holdings

Urmimala Biswas headshot

Invest in 3 Top-Performing Sectors for Gains in 2H21

Amid the current market incongruity, investors should definitely invest in the best- performing sectors for secure gains ahead.

Here's Why You Should Retain Allscripts (MDRX) Stock for Now

Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and solid prospects of the Sunrise EHR platform.

Allscripts' (MDRX) Unit Inks Deal to Boost Clinical Research

Allscripts' (MDRX) unit, Veradigm, enters into a strategic partnership with PRA Health (PRAH) to expand patients' access to clinical research.

Trina Mukherjee headshot

Digital Health Momentum is Here to Stay: 3 MedTech Stocks in Focus

Here we look at three stocks, MDRX, CERN and RMD, that investors can keep a watch on the back of their robust digital health prospects.

Riya Anand headshot

3 Stocks With Telehealth Offerings for Post-Pandemic Gains

Stocks like CVS Health (CVS), Walgreens Boots Alliance (WBA) and Allscripts (MDRX) are expected to continue to grow post-pandemic on a series of remote health care product and service launches.

Here's Why You Should Retain Allscripts (MDRX) Stock for Now

Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and solid prospects of the Sunrise EHR platform.

Allscripts (MDRX), Lash Group Team Up for Better Patient Care

Allscripts' (MDRX) Veradigm enters collaboration to streamline specialty medication management for medical clinics and practices across the nation.

Allscripts (MDRX) Inches Up 0.3% on Earnings Beat in Q1

Allscripts (MDRX) witnesses a year- over- year surge in earnings during Q1.

AllScripts Healthcare (MDRX) Tops Q1 Earnings Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of 26.67% and -0.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?